title: Potentiation by a biscoclaurine alkaloid, cepharanthine, of the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin in HeLa cells.
abstract: Cepharanthine, a biscoclaurine alkaloid, causes an 8-fold enhancement of the cytotoxic effect of a conjugate of epidermal growth factor (EGF) coupled with Pseudomonas exotoxin in HeLa cells. Cepharanthine also potentiates the effect of Pseudomonas exotoxin. Cepharanthine does not affect the binding and uptake of 125I-EGF by HeLa cells, but it delays the release of radioactivity associated with 125I-EGF into the medium. Analysis by colloidal silica gradients using cell homogenates suggests that 125I-EGF accumulates in the lysosomes of cells treated with cepharanthine and that [3H]cepharanthine accumulates in lysosomes. The pH in HeLa cell lysosomes is 5.2, and cepharanthine does not significantly increase the pH. Electron microscopy shows an increased number of electron-dense bodies and dilated Golgi apparatus after cepharanthine treatment. Cepharanthine appears to accumulate in lysosomes, and it may delay degradation of EGF-Pseudomonas exotoxin in the cells as does 125I-EGF.
authors.affiliation: Department of Biochemistry, Oita Medical School, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Shiraishi
authors.forename: T
authors.initials: T
authors.lastname: Shimada
authors.forename: Y
authors.initials: Y
authors.lastname: Hagino
authors.forename: K
authors.initials: K
authors.lastname: Kohno
authors.forename: M
authors.initials: M
authors.lastname: Kobayashi
authors.forename: M
authors.initials: M
authors.lastname: Kuwano
authors.forename: S
authors.initials: S
authors.lastname: Akiyama
mesh_terms: D036002:ADP Ribose Transferases; D000470:Alkaloids / Q000493:pharmacokinetics / Q000494:pharmacology*; D001427:Bacterial Toxins; D044182:Benzylisoquinolines; D002470:Cell Survival / Q000187:drug effects; D004357:Drug Synergism; D004815:Epidermal Growth Factor / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D005098:Exotoxins / Q000008:administration & dosage / Q000494:pharmacology*; D006367:HeLa Cells / Q000187:drug effects / Q000648:ultrastructure; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008247:Lysosomes / Q000187:drug effects; D014018:Tissue Distribution; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A; D052117:Benzodioxoles
chemical_list: D036002:ADP Ribose Transferases; D000470:Alkaloids; D001427:Bacterial Toxins; D044182:Benzylisoquinolines; D004815:Epidermal Growth Factor; D005098:Exotoxins; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A; C006947:cepharanthine; D052117:Benzodioxoles